DDReg pharma

Quailty Driven by Passion

Submit Query

All Category

Home » All Category

Artificial Intelligence (AI) in Life Sciences: Ethics, Regulatory Frameworks, and Governance for Responsible Innovation 

All Category, Blogs, regulatory /

The integration of Artificial Intelligence (AI) in the life sciences sector has ushered in a new era of innovation enabling precision drug discovery, streamlining clinical trial operations, automating regulatory workflows, and personalizing therapeutic interventions. However, as AI capabilities advance, so do the ethical concerns, regulatory scrutiny, and governance challenges surrounding its responsible deployment.  This article […]

Artificial Intelligence (AI) in Life Sciences: Ethics, Regulatory Frameworks, and Governance for Responsible Innovation  Read More »

Quasi Drugs in Japan and South Korea

Quasi Drugs: Regulatory & Commercial Considerations for Japan and South Korea 

All Category, Blogs, Regulatory /

In the dynamic Asia-Pacific market, quasi drugs represent a unique regulatory category that bridges the gap between cosmetics and pharmaceuticals. Particularly in Japan and South Korea, quasi drugs have gained traction for their hybrid benefits offering therapeutic claims while maintaining a relatively simpler regulatory pathway compared to full-fledged drugs.    Understanding the regulatory and commercial

Quasi Drugs: Regulatory & Commercial Considerations for Japan and South Korea  Read More »

US FDA launches AI tool to reduce time taken for scientific reviews

FDA Launches Gen AI Tool Elsa for Scientific Reviews

All Category, Clinical Regulatory, Insights, Regulatory /

In a watershed moment for regulatory innovation, the U.S. Food and Drug Administration (FDA) has announced the successful completion of its first AI-assisted scientific review pilot, signaling a bold step forward in modernizing the agency’s internal operations. The announcement, made by FDA Commissioner Dr. Martin A. Makary on May 8, 2025, sets forth an ambitious

FDA Launches Gen AI Tool Elsa for Scientific Reviews Read More »

Understanding the Drug Registration Process in Mexico

All Category, Blogs /

The pharmaceutical market in Mexico is one of the largest in Latin America, ranked second only to Brazil. With a growing population, increased government focus on healthcare access, and rising demand for innovative therapies, Mexico presents an attractive opportunity for pharmaceutical companies seeking market expansion. However, gaining regulatory approval in this dynamic market requires a

Understanding the Drug Registration Process in Mexico Read More »

New INVIMA Plan in Regulatory Processes

New INVIMA Plan Aims to Streamline Regulatory Processes in Colombia

All Category, Insights, Regulatory /

Colombia’s healthcare sector is undergoing a regulatory transformation. In a region where bureaucratic red tape and sluggish timelines have long delayed patient access to critical medical products, Colombia’s National Institute of Drug and Food Surveillance (INVIMA) has taken a bold step toward modernization. Under the leadership of Francisco Rossi, who assumed the official directorship in

New INVIMA Plan Aims to Streamline Regulatory Processes in Colombia Read More »

Impact of International Regulatory Harmonization Initiatives on Pharmaceutical Development 

All Category, Blogs /

Pharmaceutical companies face both complex regulatory differences across countries and exciting opportunities to simplify and accelerate product development. While varied technical requirements and duplicated testing increase time and costs, international regulatory harmonization initiatives provide a path to streamline submissions, reduce redundancies, and speed global approvals.    For pharma and biotech leaders, engaging with these harmonization

Impact of International Regulatory Harmonization Initiatives on Pharmaceutical Development  Read More »

Data privacy in Global clinical trials

Data Privacy Regulations in Global Clinical Trials: What You Need to Know 

All Category, Blogs /

Imagine volunteering for a clinical trial sharing your medical history, personal habits, and even your genetic data, all for advancing science. Now imagine that data falling into the wrong hands. In an age where data is as valuable as the therapies being developed, data privacy in clinical trials has become a keystone of ethical research

Data Privacy Regulations in Global Clinical Trials: What You Need to Know  Read More »

Regulatory Pathways for Cell-Based Therapies in Oncology 

All Category, Blogs /

Cell-based therapies in oncology represent a transformative approach to cancer treatment. By leveraging the power of living cells often from the patient’s own immune system—these therapies are designed to precisely target and eliminate cancer cells. Notable examples include chimeric antigen receptor (CAR) T cell therapy, where a patient’s T cells (a type of immune cell)

Regulatory Pathways for Cell-Based Therapies in Oncology  Read More »

Key Strategies & Considerations in Remote Regulatory Inspections

Preparing for Remote Regulatory Inspections: Key Strategies & Considerations 

All Category, Blogs /

The COVID-19 pandemic catalyzed a shift in how regulatory authorities conduct inspections, accelerating the adoption of remote regulatory inspections (RRIs) as a pragmatic alternative to traditional onsite audits. While initially a contingency approach, RRIs have now evolved into a sustainable model widely accepted by health authorities such as the U.S. FDA, EMA, MHRA, and Health

Preparing for Remote Regulatory Inspections: Key Strategies & Considerations  Read More »

One Health veterinary regulations ensuring animal and public health.

One Health Framework in Veterinary Medicine & Regulations 

All Category, Blogs /

In recent years, regulatory conversations within the life sciences sector have increasingly emphasized the importance of a unified approach to human, animal, and environmental health what is now commonly referred to as the One Health framework. Far from being a conceptual model, One Health has become a practical foundation influencing regulatory policies worldwide, particularly in

One Health Framework in Veterinary Medicine & Regulations  Read More »